In cases where the risk of radiation toxicity is high, alternative treatments such as chemotherapy or targeted therapy may be considered, especially in HER2-positive lobular breast cancer patients (Feng et al., 2019; Masuda et al., 2017). This evidence concerns the gene ERBB2 and Hereditary breast cancer.